Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2).

INTRODUCTION. Severe acute respiratory syndrome due to novel Coronavirus (SARS-CoV-2) related infection (COVID-19) is characterized by severe ventilation perfusion mismatch leading to refractory hypoxemia. To date, there is no specific treatment available for COVID-19. Nitric oxide is a selective pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Chong, Su, Binxiao, Dong, Hailong, Bellavia, Andrea, Fenza, Raffaele Di, Fakhr, Bijan Safaee, Gianni, Stefano, Grassi, Luigi Giuseppe, Kacmarek, Robert, Morais, Caio Cesar Araujo, Pinciroli, Riccardo, Vassena, Emanuele, Berra, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273302/
https://www.ncbi.nlm.nih.gov/pubmed/32511534
http://dx.doi.org/10.1101/2020.03.09.20033530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273302/
https://www.ncbi.nlm.nih.gov/pubmed/32511534
http://dx.doi.org/10.1101/2020.03.09.20033530

Ejemplares similares